Significant MP calls for RBRC Strains (IMPC_001)  

 

Total number of results: 411

Gene / Allele Procedure Parameter Zygosity Sex Phenotype P-value Graph
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dbn1
Dbn1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dbn1
Dbn1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Atp6v0a4
Atp6v0a4tm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Atp6v0a4
Atp6v0a4tm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Wasf2
Wasf2em1Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Wasf2
Wasf2em1Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Edn2
Edn2tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Edn2
Edn2tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Clspn
Clspntm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Clspn
Clspntm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Vps11
Vps11em1Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Vps11
Vps11em1Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Trpc3
Trpc3tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Trpc3
Trpc3tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Trf
Trfem1Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Trf
Trfem1Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Mat2a
Mat2atm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mat2a
Mat2atm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Sec24d
Sec24dem1Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Sec24d
Sec24dem1Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Rufy3
Rufy3tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Rufy3
Rufy3tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Sept5
Sept5tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Sept5
Sept5tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Katna1
Katna1em1Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Katna1
Katna1em1Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Pomc
Pomcem1Rbrc
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Pomc
Pomcem1Rbrc
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Wasf2
Wasf2em1Rbrc
Gross Pathology and Tissue Collection Stomach heterozygote Male abnormal stomach morphology 0.0
Wasf2
Wasf2em1Rbrc
Gross Pathology and Tissue Collection Stomach heterozygote Female abnormal stomach morphology 0.0
Sec24d
Sec24dem1Rbrc
Gross Pathology and Tissue Collection Stomach heterozygote Male abnormal stomach morphology 0.0
Rufy3
Rufy3tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Stomach heterozygote Female abnormal stomach morphology 0.0
Ftl2-ps
Ftl2-psem1Rbrc
Gross Pathology and Tissue Collection Heart homozygote Female abnormal heart morphology 0.0
Lrrc30
Lrrc30em1Rbrc
Gross Pathology and Tissue Collection Heart homozygote Male enlarged heart 0.0
Ftl2-ps
Ftl2-psem1Rbrc
Gross Pathology and Tissue Collection Heart homozygote Female enlarged heart 0.0
Katna1
Katna1em1Rbrc
Gross Pathology and Tissue Collection Epididymis heterozygote Male abnormal epididymis morphology 0.0
Katna1
Katna1em1Rbrc
Gross Pathology and Tissue Collection Epididymis heterozygote Male enlarged epididymis 0.0
Katna1
Katna1em1Rbrc
Gross Pathology and Tissue Collection Testes heterozygote Male enlarged testis 0.0
D1Pas1
D1Pas1tm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Testes homozygote Male small testis 0.0
Lrrc30
Lrrc30em1Rbrc
Gross Pathology and Tissue Collection Thymus homozygote Male small thymus 0.0
Stx7
Stx7em1Rbrc
Gross Pathology and Tissue Collection Thymus homozygote Male small thymus 0.0
Lrrc30
Lrrc30em1Rbrc
Gross Pathology and Tissue Collection Lymph node homozygote Female enlarged lymph nodes 0.0
Lrrc30
Lrrc30em1Rbrc
Gross Pathology and Tissue Collection Lymph node homozygote Male enlarged lymph nodes 0.0
Stx7
Stx7em1Rbrc
Gross Pathology and Tissue Collection Thymus homozygote Male abnormal thymus morphology 0.0
Sec24d
Sec24dem1Rbrc
Gross Pathology and Tissue Collection Liver heterozygote Male abnormal liver morphology 0.0
Izumo1r
Izumo1rtm1b(KOMP)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ppp4r1
Ppp4r1em1Rbrc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
D1Pas1
D1Pas1tm1(KOMP)Vlcg
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Liver homozygote Male small liver 0.0
Sept5
Sept5tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Spleen heterozygote Female small spleen 0.0
Lrrc30
Lrrc30em1Rbrc
Gross Pathology and Tissue Collection Spleen homozygote Male small spleen 0.0
Penk
Penktm1(KOMP)Mbp
Gross Pathology and Tissue Collection Testes homozygote Male absent testes 0.0
Tgm3
Tgm3tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Kidney homozygote Female abnormal kidney morphology 0.0
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney heterozygote Female abnormal kidney morphology 0.0
Ikzf4
Ikzf4em1Rbrc
Gross Pathology and Tissue Collection Kidney homozygote Female abnormal kidney morphology 0.0
Agtr1a
Agtr1aem1Rbrc
Gross Pathology and Tissue Collection Kidney homozygote Male abnormal kidney morphology 0.0
Agtr1a
Agtr1aem1Rbrc
Gross Pathology and Tissue Collection Kidney homozygote Female abnormal kidney morphology 0.0
Cck
Ccktm2b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney homozygote Male abnormal kidney morphology 0.0
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 1.1954074293083385E-19
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 1.1954074293083385E-19
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 3.133858019682049E-19
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 3.133858019682049E-19
Tfr2
Tfr2em1Rbrc
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 7.702415833891517E-19
Tfr2
Tfr2em1Rbrc
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 7.702415833891517E-19
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 8.838597519081971E-19
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 8.838597519081971E-19
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 1.053415647459623E-18
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 1.053415647459623E-18
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 1.6572932701848261E-18
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 1.6572932701848261E-18
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 6.003487047959294E-18
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 6.003487047959294E-18
Pdyn
Pdynem1Rbrc
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 1.1924422297966408E-17
Pdyn
Pdynem1Rbrc
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 1.1924422297966408E-17
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 2.988936079760335E-17
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 2.988936079760335E-17
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 4.0553654496045254E-17
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 4.0553654496045254E-17
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Female decreased prepulse inhibition 5.0315100408220226E-17
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Male decreased prepulse inhibition 5.0315100408220226E-17
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 7.44198515246198E-17
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 7.44198515246198E-17
Tfr2
Tfr2em1Rbrc
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 1.0215126684891726E-16
Tfr2
Tfr2em1Rbrc
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 1.0215126684891726E-16
Ppp4r1
Ppp4r1em1Rbrc
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 1.217302150490187E-16
Ppp4r1
Ppp4r1em1Rbrc
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 1.217302150490187E-16
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 2.1874350577134449E-16
Ddrgk1
Ddrgk1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 2.1874350577134449E-16
Sst
Ssttm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female increased total body fat amount 4.786038436869848E-16
Sst
Ssttm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male increased total body fat amount 4.786038436869848E-16
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 4.845189394554576E-16
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 4.845189394554576E-16
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 4.963505603605017E-16
Atp13a2
Atp13a2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 4.963505603605017E-16
Tgm3
Tgm3tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 5.75729353039932E-16
Tgm3
Tgm3tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 5.75729353039932E-16
Gucy2c
Gucy2cem1Rbrc
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 6.721430370798304E-16
Gucy2c
Gucy2cem1Rbrc
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 6.721430370798304E-16
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 6.841777870735379E-16
Gal
Galtm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 6.841777870735379E-16
Edn2
Edn2tm1b(KOMP)Mbp
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 7.516756721183057E-16
Edn2
Edn2tm1b(KOMP)Mbp
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 7.516756721183057E-16
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Combined SHIRPA and Dysmorphology Skin color - front paws heterozygote Male abnormal skin coloration 8.84019593808225E-16
Npsr1
Npsr1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 9.185014580580003E-16
Npsr1
Npsr1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 9.185014580580003E-16
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 9.24578390058958E-16
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 9.24578390058958E-16
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 9.793382230660012E-16
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 9.793382230660012E-16
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - Global homozygote Male decreased prepulse inhibition 1.4099082576822931E-15
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 1.7215741365036313E-15
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 1.7215741365036313E-15
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 2.8988830175842757E-15
Psmf1
Psmf1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 2.8988830175842757E-15
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 2.9859616044520436E-15
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 2.9859616044520436E-15
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 3.556560055413983E-15
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 3.556560055413983E-15
Edn2
Edn2tm1b(KOMP)Mbp
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 4.105353548972991E-15
Edn2
Edn2tm1b(KOMP)Mbp
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 4.105353548972991E-15
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Female abnormal coat/hair pigmentation 6.969448923413533E-15
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Female abnormal coat/hair pigmentation 6.969448923413533E-15
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Female abnormal coat/hair pigmentation 6.969448923413533E-15
Trpc5
Trpc5tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST hemizygote Male prolonged ST segment 1.0284165825793362E-14
Ppp4r1
Ppp4r1em1Rbrc
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 1.4686367153329306E-14
Ppp4r1
Ppp4r1em1Rbrc
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 1.4686367153329306E-14
Gucy2c
Gucy2cem1Rbrc
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 2.29068811987386E-14
Gucy2c
Gucy2cem1Rbrc
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 2.29068811987386E-14
Tgm3
Tgm3tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 3.563468625538378E-14
Tgm3
Tgm3tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 3.563468625538378E-14
Trpc5
Trpc5tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 4.190133415476853E-14
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 4.690525582957267E-14
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 4.690525582957267E-14
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 1.882633317903254E-13
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 1.882633317903254E-13
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 1.9630595705835002E-13
Adcyap1r1
Adcyap1r1tm1e.1(KOMP)Wtsi
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 1.9630595705835002E-13
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindpaw - shape homozygote Female abnormal autopod morphology 4.146822045903581E-13
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Combined SHIRPA and Dysmorphology Skin color - front paws heterozygote Female abnormal skin coloration 4.146822045903581E-13
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Forelimb digit - size homozygote Female abnormal digit morphology 4.146822045903581E-13
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - shape homozygote Female abnormal digit morphology 4.146822045903581E-13
Trpc5
Trpc5tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc hemizygote Male prolonged QT interval 6.290877649535453E-13
Npsr1
Npsr1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 1.5175053054428123E-12
Npsr1
Npsr1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 1.5175053054428123E-12
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 2.7913244632360446E-12
Dbn1
Dbn1tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 2.7913244632360446E-12
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - morphology homozygote Female abnormal tail morphology 2.8975480868831394E-12
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Male abnormal coat/hair pigmentation 2.934060980286368E-12
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Male abnormal coat/hair pigmentation 2.934060980286368E-12
Rln3
Rln3tm1(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Male abnormal coat/hair pigmentation 2.934060980286368E-12
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 5.272168552422629E-12
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 5.272168552422629E-12
Cck
Ccktm2b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 9.591704167033477E-12
Cck
Ccktm2b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 9.591704167033477E-12
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - morphology homozygote Male abnormal tail morphology 1.1715029987757752E-11
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 1.6075604389320652E-11
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 1.6075604389320652E-11
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Albumin homozygote Male increased circulating serum albumin level 2.1087246532269788E-11
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 2.5689055049848974E-11
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 2.5689055049848974E-11
Tfr2
Tfr2em1Rbrc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 3.147607521847284E-11
Tfr2
Tfr2em1Rbrc
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 3.147607521847284E-11
Pdyn
Pdynem1Rbrc
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 4.336638687041372E-11
Pdyn
Pdynem1Rbrc
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 4.336638687041372E-11
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 5.063451741227354E-11
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 5.063451741227354E-11
Trpc5
Trpc5tm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 5.7127191865902205E-11
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 5.738642547270523E-11
Vps39
Vps39tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 5.738642547270523E-11
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte cell count homozygote Female decreased lymphocyte cell number 7.57920184946137E-11
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte cell count homozygote Male decreased lymphocyte cell number 7.57920184946137E-11
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology White blood cell count homozygote Female decreased leukocyte cell number 8.786150973438822E-11
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology White blood cell count homozygote Male decreased leukocyte cell number 8.786150973438822E-11
Sept5
Sept5tm1b(EUCOMM)Hmgu
Hematology Platelet count heterozygote Female thrombocytopenia 9.607298984137813E-11
Sept5
Sept5tm1b(EUCOMM)Hmgu
Hematology Platelet count heterozygote Male thrombocytopenia 9.607298984137813E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - length homozygote Female abnormal tail length 9.890171320803276E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - size homozygote Female abnormal digit morphology 9.890171320803276E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tail - length homozygote Male abnormal tail length 9.993841171285212E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindpaw - shape homozygote Male abnormal autopod morphology 9.993841171285212E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Forelimb digit - size homozygote Male abnormal digit morphology 9.993841171285212E-11
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - shape homozygote Male abnormal digit morphology 9.993841171285212E-11
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Mean corpuscular hemoglobin homozygote Female decreased mean corpuscular hemoglobin 1.3844683732777696E-10
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 1.3844683732777696E-10
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 1.512258235303321E-10
Uts2
Uts2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 1.512258235303321E-10
Cck
Ccktm2b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 2.49317760880885E-10
Cck
Ccktm2b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 2.49317760880885E-10
Tfr2
Tfr2em1Rbrc
Clinical Chemistry Iron homozygote Female increased circulating iron level 3.8478253916451877E-10
Tfr2
Tfr2em1Rbrc
Clinical Chemistry Iron homozygote Male increased circulating iron level 3.8478253916451877E-10
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Female increased glycosylated hemoglobin level 5.45514633465416E-10
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Male increased glycosylated hemoglobin level 5.45514633465416E-10
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 5.992286111755618E-10
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 5.992286111755618E-10
Tyms
Tymstm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 1.3902826667688828E-9
Tyms
Tymstm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 1.3902826667688828E-9
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 1.7128680696032461E-9
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 1.7128680696032461E-9
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Female short tibia 1.9050494515227E-9
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Male short tibia 1.9050494515227E-9
Tyms
Tymstm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 3.1620972507084844E-9
Tyms
Tymstm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 3.1620972507084844E-9
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 3.1673901279560823E-9
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 3.1673901279560823E-9
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 6.332050439539216E-9
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 6.332050439539216E-9
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female increased bone mineral content 6.51078702063046E-9
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male increased bone mineral content 6.51078702063046E-9
Apln
Aplntm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST hemizygote Male prolonged ST segment 7.14903203302697E-9
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female increased startle reflex 8.425175224147097E-9
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male increased startle reflex 8.425175224147097E-9
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Brachydactyly homozygote Female brachydactyly 1.433150043084197E-8
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Brachydactyly homozygote Male brachydactyly 1.433150043084197E-8
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Red blood cell distribution width homozygote Female increased red blood cell distribution width 1.4747453036534353E-8
Hbb-bh2
Hbb-bh2tm1b(EUCOMM)Hmgu
Hematology Red blood cell distribution width homozygote Male increased red blood cell distribution width 1.4747453036534353E-8
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 1.6747687681117895E-8
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 1.6747687681117895E-8
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 1.7477802316534508E-8
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.7477802316534508E-8
Apln
Aplntm1b(KOMP)Wtsi
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 2.1801378480290623E-8
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Iron homozygote Male increased circulating iron level 2.955924927050546E-8
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Neutrophil differential count homozygote Female increased neutrophil cell number 3.163265915873126E-8
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Neutrophil differential count homozygote Male increased neutrophil cell number 3.163265915873126E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Total bilirubin homozygote Female increased circulating bilirubin level 3.621493149807975E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Total bilirubin homozygote Male increased circulating bilirubin level 3.621493149807975E-8
Sec24d
Sec24dem1Rbrc
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male impaired glucose tolerance 4.734787140137087E-8
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Female decreased circulating alkaline phosphatase level 5.369945554889455E-8
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Male decreased circulating alkaline phosphatase level 5.369945554889455E-8
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Male decreased prepulse inhibition 5.84645363232994E-8
Pomc
Pomcem1Rbrc
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Female increased total body fat amount 5.941223690797415E-8
Pomc
Pomcem1Rbrc
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male increased total body fat amount 5.941223690797415E-8
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Female cardiovascular system phenotype 1.3057859860055032E-7
Sept5
Sept5tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Male cardiovascular system phenotype 1.3057859860055032E-7
Trf
Trfem1Rbrc
Clinical Chemistry Iron heterozygote Female decreased circulating iron level 1.339454485105307E-7
Trf
Trfem1Rbrc
Clinical Chemistry Iron heterozygote Male decreased circulating iron level 1.339454485105307E-7
Apln
Aplntm1b(KOMP)Wtsi
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 1.9673544215947913E-7
Sept5
Sept5tm1b(EUCOMM)Hmgu
X-ray Tibia length heterozygote Female short tibia 2.2986866099472536E-7
Sept5
Sept5tm1b(EUCOMM)Hmgu
X-ray Tibia length heterozygote Male short tibia 2.2986866099472536E-7
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Pelvis homozygote Male abnormal pelvic girdle bone morphology 2.9561098813246645E-7
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI4 homozygote Female decreased prepulse inhibition 3.5336003634256485E-7
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI4 homozygote Male decreased prepulse inhibition 3.5336003634256485E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Respiratory Exchange Ratio homozygote Female decreased respiratory quotient 3.5697621569852345E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Respiratory Exchange Ratio homozygote Male decreased respiratory quotient 3.5697621569852345E-7
Fdx1l
Fdx1lem1Rbrc
Clinical Chemistry Creatine kinase homozygote Female decreased circulating creatine kinase level 3.635526866219152E-7
Fdx1l
Fdx1lem1Rbrc
Clinical Chemistry Creatine kinase homozygote Male decreased circulating creatine kinase level 3.635526866219152E-7
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte differential count homozygote Female decreased lymphocyte cell number 3.7059629676150507E-7
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Lymphocyte differential count homozygote Male decreased lymphocyte cell number 3.7059629676150507E-7
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) CV heterozygote Female cardiovascular system phenotype 4.362152594694635E-7
Slc2a2
Slc2a2tm1b(KOMP)Wtsi
Electrocardiogram (ECG) CV heterozygote Male cardiovascular system phenotype 4.362152594694635E-7
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Alpha-amylase homozygote Female decreased circulating amylase level 4.597675058448658E-7
Sst
Ssttm1b(KOMP)Wtsi
Clinical Chemistry Alpha-amylase homozygote Male decreased circulating amylase level 4.597675058448658E-7
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Female cardiovascular system phenotype 5.0273098395337E-7
Nin
Nintm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Male cardiovascular system phenotype 5.0273098395337E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Distance travelled - total homozygote Female hyperactivity 5.700511565009947E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Distance travelled - total homozygote Male hyperactivity 5.700511565009947E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Whole arena average speed homozygote Female hyperactivity 5.708664048142964E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Whole arena average speed homozygote Male hyperactivity 5.708664048142964E-7
Prkab1
Prkab1tm1b(KOMP)Wtsi
X-ray Number of caudal vertebrae homozygote decreased caudal vertebrae number 6.000000212225132E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Indirect Calorimetry Respiratory Exchange Ratio homozygote Female decreased respiratory quotient 6.275930672927643E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Indirect Calorimetry Respiratory Exchange Ratio homozygote Male decreased respiratory quotient 6.275930672927643E-7
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 6.627361699429457E-7
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 6.627361699429457E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 6.855356105006649E-7
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 6.855356105006649E-7
Stx7
Stx7em1Rbrc
Hematology Large Unstained Cell (LUC) differential count homozygote Female decreased large unstained cell number 7.512537649745354E-7
Stx7
Stx7em1Rbrc
Hematology Large Unstained Cell (LUC) differential count homozygote Male decreased large unstained cell number 7.512537649745354E-7
Rnf10
Rnf10tm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Female decreased mean corpuscular hemoglobin 7.87549652159214E-7
Rnf10
Rnf10tm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 7.87549652159214E-7
Nxn
Nxntm1b(EUCOMM)Wtsi
X-ray Tibia length heterozygote Female short tibia 7.941137596390035E-7
Nxn
Nxntm1b(EUCOMM)Wtsi
X-ray Tibia length heterozygote Male short tibia 7.941137596390035E-7
Pdyn
Pdynem1Rbrc
Electrocardiogram (ECG) QRS homozygote Female shortened QRS complex duration 8.497287353748106E-7
Pdyn
Pdynem1Rbrc
Electrocardiogram (ECG) QRS homozygote Male shortened QRS complex duration 8.497287353748106E-7
Atp6v1g2
Atp6v1g2em1Rbrc
Open Field Center average speed homozygote Female abnormal behavior 8.797900932222547E-7
Atp6v1g2
Atp6v1g2em1Rbrc
Open Field Center average speed homozygote Male abnormal behavior 8.797900932222547E-7
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Alpha-amylase homozygote Female decreased circulating amylase level 1.0472205076439423E-6
Prkab1
Prkab1tm1b(KOMP)Wtsi
Clinical Chemistry Alpha-amylase homozygote Male decreased circulating amylase level 1.0472205076439423E-6
Vps11
Vps11em1Rbrc
Clinical Chemistry Lactate dehydrogenase heterozygote Female decreased circulating lactate dehydrogenase level 1.0868308208955568E-6
Vps11
Vps11em1Rbrc
Clinical Chemistry Lactate dehydrogenase heterozygote Male decreased circulating lactate dehydrogenase level 1.0868308208955568E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Female abnormal sensory capabilities/reflexes/nociception 1.160727379101445E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Male abnormal sensory capabilities/reflexes/nociception 1.160727379101445E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol homozygote Male decreased circulating HDL cholesterol level 1.3832703871230478E-6
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Basophil cell count homozygote Female decreased basophil cell number 1.3942085388407577E-6
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Basophil cell count homozygote Male decreased basophil cell number 1.3942085388407577E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response Click-evoked ABR threshold homozygote increased or absent threshold for auditory brainstem response 1.500000053056283E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 18kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.500000053056283E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 24kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.500000053056283E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response Click-evoked ABR threshold homozygote increased or absent threshold for auditory brainstem response 1.500000053056283E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 30kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.6000000186977559E-6
Sst
Ssttm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Female improved glucose tolerance 1.8046706600216567E-6
Sst
Ssttm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male improved glucose tolerance 1.8046706600216567E-6
Katna1
Katna1em1Rbrc
Clinical Chemistry Lactate dehydrogenase heterozygote Female decreased circulating lactate dehydrogenase level 1.8186037777923048E-6
Katna1
Katna1em1Rbrc
Clinical Chemistry Lactate dehydrogenase heterozygote Male decreased circulating lactate dehydrogenase level 1.8186037777923048E-6
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Gait homozygote Female abnormal gait 1.8870609892474022E-6
Kif2c
Kif2ctm1.1(KOMP)Vlcg
Combined SHIRPA and Dysmorphology Skin color - back paws heterozygote Female abnormal skin coloration 1.8870609892474022E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - size homozygote Male abnormal digit morphology 1.898879986583779E-6
Sst
Ssttm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 2.185794073739089E-6
Stx7
Stx7em1Rbrc
Clinical Chemistry Lactate dehydrogenase homozygote Female decreased circulating lactate dehydrogenase level 2.475211204000516E-6
Stx7
Stx7em1Rbrc
Clinical Chemistry Lactate dehydrogenase homozygote Male decreased circulating lactate dehydrogenase level 2.475211204000516E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 2.5609404019633075E-6
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 2.5609404019633075E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Female cardiovascular system phenotype 2.6198649720754474E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV homozygote Male cardiovascular system phenotype 2.6198649720754474E-6
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Hematology Lymphocyte cell count homozygote Male increased lymphocyte cell number 3.8734933696105145E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
X-ray Pelvis homozygote Female abnormal pelvic girdle bone morphology 6.807747922721319E-6
Nin
Nintm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 7.099999947968172E-6
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 7.099999947968172E-6
Rln3
Rln3tm1(KOMP)Mbp
Open Field Center resting time homozygote Female abnormal behavior 7.656969501113053E-6
Rln3
Rln3tm1(KOMP)Mbp
Open Field Center resting time homozygote Male abnormal behavior 7.656969501113053E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Periphery distance travelled homozygote Female hyperactivity 7.957960406201892E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Periphery distance travelled homozygote Male hyperactivity 7.957960406201892E-6
Tfr2
Tfr2em1Rbrc
Hematology Red blood cell count homozygote Female decreased erythrocyte cell number 9.056869203050155E-6
Tfr2
Tfr2em1Rbrc
Hematology Red blood cell count homozygote Male decreased erythrocyte cell number 9.056869203050155E-6
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Platelet count homozygote Female thrombocytopenia 1.0135969205293804E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Platelet count homozygote Male thrombocytopenia 1.0135969205293804E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 1.0224312973150518E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 1.0224312973150518E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Large Unstained Cell (LUC) count homozygote Female decreased large unstained cell number 1.0235378795186989E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Hematology Large Unstained Cell (LUC) count homozygote Male decreased large unstained cell number 1.0235378795186989E-5
Penk
Penktm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 1.254626113222912E-5
Penk
Penktm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.254626113222912E-5
Nin
Nintm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Male decreased prepulse inhibition 1.2575101209222339E-5
Ube2g1
Ube2g1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 6kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 1.2800000149582047E-5
Stx7
Stx7em1Rbrc
Hematology Large Unstained Cell (LUC) count homozygote Female decreased large unstained cell number 1.2996494660910685E-5
Stx7
Stx7em1Rbrc
Hematology Large Unstained Cell (LUC) count homozygote Male decreased large unstained cell number 1.2996494660910685E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Mean corpuscular hemoglobin homozygote Female decreased mean corpuscular hemoglobin 1.4041220310900826E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 1.4041220310900826E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Female decreased hemoglobin content 1.4398761777556501E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Male decreased hemoglobin content 1.4398761777556501E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Tibia length homozygote Female short tibia 1.4571717656508554E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
X-ray Tibia length homozygote Male short tibia 1.4571717656508554E-5
Sst
Ssttm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.711177537799813E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Center average speed homozygote Female abnormal behavior 1.7464981283410452E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Center average speed homozygote Male abnormal behavior 1.7464981283410452E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Female decreased bone mineral content 1.8950495359604247E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Male decreased bone mineral content 1.8950495359604247E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Female improved glucose tolerance 1.9807035641861148E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male improved glucose tolerance 1.9807035641861148E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 2.2216825527721085E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 2.2216825527721085E-5
Galp
Galptm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Male hyperactivity 2.288013456563931E-5
Galp
Galptm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Female hypoactivity 2.288013456563931E-5
Gypc
Gypcem1Rbrc
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Female decreased glycosylated hemoglobin level 2.4064760509645566E-5
Gypc
Gypcem1Rbrc
Clinical Chemistry Glycosilated hemoglobin A1c (HbA1c) homozygote Male decreased glycosylated hemoglobin level 2.4064760509645566E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Female increased circulating cholesterol level 2.5280998670496047E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Male increased circulating cholesterol level 2.5280998670496047E-5
Ikzf3
Ikzf3tm1(KOMP)Vlcg
Grip Strength Forelimb grip strength measurement mean homozygote Male increased grip strength 2.7676056561176665E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Electrocardiogram (ECG) ST homozygote Female prolonged ST segment 2.7837837478728034E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 2.7837837478728034E-5
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Female cardiovascular system phenotype 2.868849696824327E-5
Dctn2
Dctn2tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) CV heterozygote Male cardiovascular system phenotype 2.868849696824327E-5
Clspn
Clspntm1(KOMP)Vlcg
Electrocardiogram (ECG) ST heterozygote Female prolonged ST segment 3.144352012895979E-5
Clspn
Clspntm1(KOMP)Vlcg
Electrocardiogram (ECG) ST heterozygote Male prolonged ST segment 3.144352012895979E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Eosinophil differential count homozygote Female decreased eosinophil cell number 3.3367250580340624E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Hematology Eosinophil differential count homozygote Male decreased eosinophil cell number 3.3367250580340624E-5
Ptprm
Ptprmem1Rbrc
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 3.352125349920243E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 3.387177275726572E-5
Hbq1a
Hbq1atm1.1(KOMP)Vlcg
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 3.387177275726572E-5
Ikzf5
Ikzf5tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 3.4402844903524965E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Fat mass homozygote Female increased total body fat amount 3.5830496926791966E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
Body Composition (DEXA lean/fat) Fat mass homozygote Male increased total body fat amount 3.5830496926791966E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Total food intake homozygote Female decreased food intake 3.6295077734394E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Total food intake homozygote Male decreased food intake 3.6295077734394E-5
Rln3
Rln3tm1(KOMP)Mbp
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 4.013736906927079E-5
Rln3
Rln3tm1(KOMP)Mbp
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male decreased bone mineral content 4.013736906927079E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Whole arena resting time homozygote Female hyperactivity 4.262874790583737E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Whole arena resting time homozygote Male hyperactivity 4.262874790583737E-5
Atp6v1g2
Atp6v1g2em1Rbrc
Open Field Periphery distance travelled homozygote Female hyperactivity 4.266707401257008E-5
Atp6v1g2
Atp6v1g2em1Rbrc
Open Field Periphery distance travelled homozygote Male hyperactivity 4.266707401257008E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 4.297044506529346E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 4.297044506529346E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Hematology White blood cell count homozygote Male increased leukocyte cell number 4.607356822816655E-5
Ppp4r1
Ppp4r1em1Rbrc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female increased bone mineral content 4.615268699126318E-5
Ppp4r1
Ppp4r1em1Rbrc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male increased bone mineral content 4.615268699126318E-5
Trf
Trfem1Rbrc
Hematology Mean corpuscular hemoglobin heterozygote Female increased mean corpuscular hemoglobin 5.232515468378551E-5
Trf
Trfem1Rbrc
Hematology Mean corpuscular hemoglobin heterozygote Male increased mean corpuscular hemoglobin 5.232515468378551E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length heterozygote Female decreased body length 5.500871338881552E-5
Sept5
Sept5tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length heterozygote Male decreased body length 5.500871338881552E-5
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Locomotor activity heterozygote Female hyperactivity 5.6468772527296096E-5
Ppp4r2
Ppp4r2tm2b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Locomotor activity heterozygote Male hyperactivity 5.6468772527296096E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Periphery average speed homozygote Female abnormal behavior 6.0450827731983736E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Open Field Periphery average speed homozygote Male abnormal behavior 6.0450827731983736E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 6.520497845485806E-5
Vps11
Vps11em1Rbrc
Clinical Chemistry Aspartate aminotransferase heterozygote Female decreased circulating aspartate transaminase level 6.773831410100684E-5
Vps11
Vps11em1Rbrc
Clinical Chemistry Aspartate aminotransferase heterozygote Male decreased circulating aspartate transaminase level 6.773831410100684E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 7.224267028504983E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Male increased circulating alkaline phosphatase level 7.224267028504983E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
X-ray Tibia length homozygote Female short tibia 7.305258623091504E-5
Ube2j1
Ube2j1tm1.1(NCOM)Mfgc
X-ray Tibia length homozygote Male short tibia 7.305258623091504E-5
Ube3c
Ube3ctm1b(EUCOMM)Hmgu
Indirect Calorimetry Total water intake homozygote Female decreased fluid intake 7.316759001696482E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male increased bone mineral content 7.710959471296519E-5
Clspn
Clspntm1(KOMP)Vlcg
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 7.917085167719051E-5
Clspn
Clspntm1(KOMP)Vlcg
Electrocardiogram (ECG) QTc heterozygote Male prolonged QT interval 7.917085167719051E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female increased total body fat amount 8.824611722957343E-5
Dnase1l2
Dnase1l2tm1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 9.976638102671131E-5